Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label study of pH-sensitive vaginal metronidazole tablet applicator versus vaginal metronidazole gel for bacterial vaginosis
MOH_2018-03-12_002242Phase 2Not yet recruiting
- Sponsor
- Eve Pharma
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Eve Pharma. Planned start Mar 2018; status: not yet recruiting.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on MOH_2018-03-12_002242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-03-12_002242.